Azizath Moussiliou
Overview
Explore the profile of Azizath Moussiliou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blankson S, Rietmeyer L, Tettey P, Dikroh L, Tornyigah B, Adamou R, et al.
Diagnostics (Basel)
. 2023 Feb;
13(3).
PMID: 36766633
Among the barriers to accessing adequate treatment and high-level monitoring for malaria febrile patients is the lack of effective prognostic markers. Neopterin, which is a marker of monocyte/macrophage activation, was...
2.
Blankson S, Dikroh L, Tettey P, Tornyigah B, Adamou R, Moussiliou A, et al.
J Infect Dis
. 2022 Nov;
227(2):179-182.
PMID: 36416015
The endothelial protein C receptor (EPCR)-rs867186 G allele has been linked to high plasma levels of soluble EPCR (sEPCR) and controversially associated with either susceptibility or resistance to severe and...
3.
Suurbaar J, Moussiliou A, Tahar R, Olsen R, Adams Y, Dalgaard N, et al.
Sci Rep
. 2022 Jul;
12(1):12994.
PMID: 35906450
Members of the highly polymorphic Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family expressed on the surface of infected erythrocytes (IEs) are important virulence factors, which mediate vascular adhesion of...
4.
Tornyigah B, Blankson S, Adamou R, Moussiliou A, Rietmeyer L, Tettey P, et al.
Diagnostics (Basel)
. 2022 Feb;
12(2).
PMID: 35204613
Malaria-related deaths could be prevented if powerful diagnostic and reliable prognostic biomarkers were available to allow rapid prediction of the clinical severity allowing adequate treatment. Using quantitative ELISA, we assessed...
5.
Lagnika H, Moussiliou A, Agonhossou R, Sovegnon P, Djihinto O, Medjigbodo A, et al.
Parasitol Res
. 2022 Jan;
121(1):167-175.
PMID: 34993632
Symptomatic and asymptomatic malaria patients are considered as the reservoirs of human Plasmodium. In the present study, we have evaluated the Plasmodium falciparum merozoite surface protein-1 (Pfmsp1) and protein-2 (Pfmsp2)...
6.
Doritchamou J, Akuffo R, Moussiliou A, Luty A, Massougbodji A, Deloron P, et al.
PLoS Negl Trop Dis
. 2018 Feb;
12(2):e0006279.
PMID: 29432484
Background: Among the Plasmodium species that infect humans, adverse effects of P. falciparum and P. vivax have been extensively studied and reported with respect to poor outcomes particularly in first...
7.
Ndam N, Moussiliou A, Lavstsen T, Kamaliddin C, Jensen A, Mama A, et al.
J Infect Dis
. 2017 Sep;
215(12):1918-1925.
PMID: 28863469
Background: Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) mediates the binding and accumulation of infected erythrocytes (IE) to blood vessels and tissues. Specific interactions have been described between PfEMP1 and...
8.
Lennartz F, Adams Y, Bengtsson A, Olsen R, Turner L, Ndam N, et al.
Cell Host Microbe
. 2017 Mar;
21(3):403-414.
PMID: 28279348
Cerebral malaria is a deadly outcome of infection by Plasmodium falciparum, occurring when parasite-infected erythrocytes accumulate in the brain. These erythrocytes display parasite proteins of the PfEMP1 family that bind...
9.
Nunes-Silva S, Dechavanne S, Moussiliou A, Pstrag N, Semblat J, Gangnard S, et al.
Malar J
. 2016 Jan;
15:22.
PMID: 26755189
No abstract available.
10.
Nunes-Silva S, Dechavanne S, Moussiliou A, Pstrag N, Semblat J, Gangnard S, et al.
Malar J
. 2015 Dec;
14:493.
PMID: 26646943
Background: Malaria is still one of the most prevalent infectious diseases in the world. Sequestration of infected erythrocytes (IEs) is the prime mediator of disease. Cytoadhesion of IEs is mediated...